Key facts
- This page summarizes Bob Lapetina's Form 3 filing for Immunome Inc. (IMNM).
- 0 reported transactions and 4 derivative rows are listed below.
- Accepted by SEC: 04 Jan 2024, 17:40.
Bob Lapetina - 02 Jan 2024 Form 3 Insider Report for Immunome Inc. (IMNM)
- Reporting relationship
- PAO and VP Finance & Corporate
- Issuer ticker
- IMNM
- Reported as of
- 02 Jan 2024
- Net transaction value
- $0
- SEC form
- 3
- Accepted by SEC
- 04 Jan 2024, 17:40:31 UTC
- Next SEC filing
- 06 Aug 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Sandra Stoneman, Attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Bob Lapetina filed Form 3 for Immunome Inc. (IMNM) on 04 Jan 2024.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
IMNM
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 12,047
- Date
- 02 Jan 2024
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
IMNM
holding
Derivative
Stock option (right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 02 Jan 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 11,000
- Exercise price
- $16.59
- Footnotes
- F1
IMNM
holding
Derivative
Stock option (right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 02 Jan 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 300
- Exercise price
- $20.92
- Footnotes
- F2
IMNM
holding
Derivative
Stock option (right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 02 Jan 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 12,000
- Exercise price
- $3.42
- Footnotes
- F3
IMNM
holding
Derivative
Stock option (right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 02 Jan 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 17,600
- Exercise price
- $4.84
- Footnotes
- F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
25% of the shares subject to the options vest on May 12, 2022, and one-thirty-sixth (1/36th) of the remaining shares subject to the options shall vest every month thereafter.
Footnote F2
25% of the shares subject to the options vest on May 28, 2022, and one-thirty-sixth (1/36th) of the remaining shares subject to the options shall vest every month thereafter.
Footnote F3
25% of the shares subject to the options vest on May 27, 2023, and one-thirty-sixth (1/36th) of the remaining shares subject to the options shall vest every month thereafter.
Footnote F4
25% of the shares subject to the options vest on June 8, 2024, and one-thirty-sixth (1/36th) of the remaining shares subject to the options shall vest every month thereafter.
SEC remarks
See Attached Exhibit 24